SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-17-006801
Filing Date
2017-07-19
Accepted
2017-07-19 08:44:27
Documents
4
Period of Report
2017-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1702157_8k.htm 8-K 19180
2 EXHIBIT 99.1 t1702157_ex99-1.htm EX-99.1 13824
3 GRAPHIC t1702157_logoex99-1.jpg GRAPHIC 10133
4 GRAPHIC t1702157_pg1ex99-1.jpg GRAPHIC 3366
  Complete submission text file 0001571049-17-006801.txt   53103
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 17970860
SIC: 2834 Pharmaceutical Preparations